Glucocorticoid Replacement and Mortality in Patients with Nonfunctioning Pituitary Adenoma

Zueger, Thomas; Kirchner, Paul; Herren, Coline; Fischli, Stefan; Zwahlen, Marcel; Christ, Emanuel; Stettler, Christoph (2012). Glucocorticoid Replacement and Mortality in Patients with Nonfunctioning Pituitary Adenoma. Journal of clinical endocrinology and metabolism, 97(10), E1938-42. Chevy Chase, Md.: Endocrine Society 10.1210/jc.2012-2432

[img] Text
Zueger JClinEndocrinolMetab 2012.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (136kB) | Request a copy

Current treatment guidelines generally suggest using lower and weight-adjusted glucocorticoid replacement doses in patients with insufficiency of the hypothalamic-pituitary-adrenal (HPA) axis. Although data in patients with acromegaly revealed a positive association between glucocorticoid dose and mortality, no comparable results exist in patients with nonfunctioning pituitary adenomas (NFPA).

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Endocrinology, Diabetology and Clinical Nutrition
04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Social and Preventive Medicine (ISPM)

UniBE Contributor:

Fischli, Stefan; Zwahlen, Marcel; Christ, Emanuel and Stettler, Christoph

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0021-972X

Publisher:

Endocrine Society

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:26

Last Modified:

08 Sep 2017 17:13

Publisher DOI:

10.1210/jc.2012-2432

PubMed ID:

22872686

Web of Science ID:

000309664400014

BORIS DOI:

10.7892/boris.9375

URI:

https://boris.unibe.ch/id/eprint/9375 (FactScience: 215105)

Actions (login required)

Edit item Edit item
Provide Feedback